Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04050527 · ClinicalTrials.gov registry record
Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort
A clinical trial, sponsored by Ipsen.
- Completed
- Registry status
- 438
- Enrollment target
NCT04050527 is a clinical trial that has completed, run by Ipsen. The registered enrollment target is 438 participants.
The verdict
NCT04050527 has completed, sponsored by Ipsen.
- COMPLETED
- Registry status
- 438 participants
- Enrollment target
Study Summary
The purpose of the protocol is to assess the longitudinal attainment of person-centered and function related goals of patients who receive AbobotulinumtoxinA (aboBoNT-A) injections for adult lower limb spasticity over a period of 16 months.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 438 participants |
| Start Date | 2019-12-19 |
| Est. Completion | 2022-07-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04050527
The ClinicalTrials.gov registry entry for NCT04050527 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 438 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ipsen, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04050527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04050527 about?
NCT04050527 is a clinical study titled "Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort". The purpose of the protocol is to assess the longitudinal attainment of person-centered and function related goals of patients who receive AbobotulinumtoxinA (aboBoNT-A) injections for adult lower limb spasticity over a period of 16 months.
What is the current status of trial NCT04050527?
This trial is currently completed. The enrollment target is 438 participants. The study started on 2019-12-19. Estimated completion is 2022-07-29.
Who is sponsoring clinical trial NCT04050527?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.